Holdings of Health Sciences Portfolio
PACIFIC SELECT FUND · Original filing · Compare with another fund · Report an error
- Net assets
- 381.4M $ including 367.6M $ in equities, 96.4 %
- Positions
- 128 in 15 countries
- Top ten
- 51.8 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 39,510 | 47.4M $ | 12.42 % |
| 2 | Johnson & Johnson | 116,707 | 29.6M $ | 7.77 % |
| 3 | UnitedHealth Group Inc | 56,143 | 23.3M $ | 6.12 % |
| 4 | Merck & Co Inc | 155,612 | 20M $ | 5.24 % |
| 5 | AbbVie Inc | 76,485 | 19.2M $ | 5.05 % |
| 6 | Gilead Sciences Inc | 110,828 | 14M $ | 3.67 % |
| 7 | Amgen Inc | 35,457 | 12.8M $ | 3.37 % |
| 8 | Thermo Fisher Scientific Inc | 22,487 | 11.3M $ | 2.96 % |
| 9 | Vertex Pharmaceuticals Inc | 21,484 | 10.7M $ | 2.80 % |
| 10 | Edwards Lifesciences Corp | 102,345 | 9.3M $ | 2.43 % |
| 11 | Abbott Laboratories | 81,496 | 7.4M $ | 1.94 % |
| 12 | Danaher Corp | 38,556 | 7.3M $ | 1.93 % |
| 13 | Elevance Health Inc | 18,292 | 7.1M $ | 1.85 % |
| 14 | Pfizer Inc | 236,611 | 5.7M $ | 1.49 % |
| 15 | Argenx SE | 5,371 | 5M $ | 1.31 % |
| 16 | Boston Scientific Corp | 116,106 | 5M $ | 1.30 % |
| 17 | Biogen Inc | 21,727 | 4.7M $ | 1.23 % |
| 18 | Teva Pharmaceutical Industries Ltd | 130,722 | 4.4M $ | 1.16 % |
| 19 | Intuitive Surgical Inc | 11,013 | 4.4M $ | 1.15 % |
| 20 | Stryker Corp | 13,291 | 4.2M $ | 1.10 % |
| 21 | REVOLUTION MEDICINES INC | 21,425 | 4M $ | 1.05 % |
| 22 | MODERNA INC | 54,421 | 3.8M $ | 1.00 % |
| 23 | Waters Corp | 10,088 | 3.8M $ | 0.99 % |
| 24 | CYTOKINETICS INC | 39,481 | 3.4M $ | 0.88 % |
| 25 | Regeneron Pharmaceuticals Inc | 5,239 | 3.3M $ | 0.86 % |
| 26 | Bristol-Myers Squibb Co | 54,342 | 3.1M $ | 0.82 % |
| 27 | Humana Inc | 7,237 | 2.9M $ | 0.75 % |
| 28 | CVS Health Corp | 27,762 | 2.9M $ | 0.75 % |
| 29 | AstraZeneca PLC | 15,175 | 2.8M $ | 0.74 % |
| 30 | Incyte Corp | 23,632 | 2.7M $ | 0.70 % |
| 31 | Dexcom Inc | 39,665 | 2.7M $ | 0.70 % |
| 32 | COGENT BIOSCIENCES INC | 68,826 | 2.7M $ | 0.70 % |
| 33 | HCA Healthcare Inc | 6,751 | 2.6M $ | 0.69 % |
| 34 | Galderma Group AG | 11,157 | 2.5M $ | 0.67 % |
| 35 | Penumbra Inc | 7,995 | 2.5M $ | 0.66 % |
| 36 | Protagonist Therapeutics Inc | 19,754 | 2.4M $ | 0.63 % |
| 37 | Nuvalent Inc | 19,497 | 2.4M $ | 0.63 % |
| 38 | Novartis AG | 14,858 | 2.3M $ | 0.61 % |
| 39 | Insmed Inc | 20,560 | 2.2M $ | 0.57 % |
| 40 | Agilent Technologies Inc | 16,087 | 2.1M $ | 0.56 % |
| 41 | Apogee Therapeutics Inc | 15,718 | 2.1M $ | 0.55 % |
| 42 | IDEXX Laboratories Inc | 3,919 | 2.1M $ | 0.54 % |
| 43 | Rhythm Pharmaceuticals Inc | 18,084 | 2M $ | 0.53 % |
| 44 | United Therapeutics Corp | 3,301 | 1.8M $ | 0.47 % |
| 45 | Illumina Inc | 9,950 | 1.7M $ | 0.46 % |
| 46 | ALNYLAM PHARMACEUTICALS INC | 5,633 | 1.7M $ | 0.44 % |
| 47 | IQVIA Holdings Inc | 8,371 | 1.6M $ | 0.42 % |
| 48 | ORUKA THERAPEUTICS INC | 15,857 | 1.5M $ | 0.40 % |
| 49 | Bruker Corp | 23,980 | 1.4M $ | 0.38 % |
| 50 | Axsome Therapeutics Inc | 5,320 | 1.3M $ | 0.34 % |
| 51 | Roivant Sciences Ltd | 36,604 | 1.3M $ | 0.34 % |
| 52 | Medline Inc | 31,350 | 1.2M $ | 0.32 % |
| 53 | McKesson Corp | 1,635 | 1.2M $ | 0.32 % |
| 54 | Kailera Therapeutics Inc | 55,117 | 1.2M $ | 0.32 % |
| 55 | Neurocrine Biosciences Inc | 6,821 | 1.1M $ | 0.30 % |
| 56 | BioMarin Pharmaceutical Inc | 19,970 | 1.1M $ | 0.30 % |
| 57 | MBX BIOSCIENCES INC | 19,741 | 1.1M $ | 0.29 % |
| 58 | LB Pharmaceuticals Inc | 33,445 | 1.1M $ | 0.28 % |
| 59 | Quest Diagnostics Inc | 5,093 | 1.1M $ | 0.28 % |
| 60 | Dianthus Therapeutics Inc | 11,071 | 1.1M $ | 0.28 % |
| 61 | ARCUS BIOSCIENCES INC | 34,390 | 1.1M $ | 0.28 % |
| 62 | UCB SA | 3,202 | 958.6K $ | 0.25 % |
| 63 | Stoke Therapeutics Inc | 28,316 | 926.5K $ | 0.24 % |
| 64 | Madrigal Pharmaceuticals Inc | 1,659 | 890.8K $ | 0.23 % |
| 65 | Bio-Techne Corp | 11,772 | 831.7K $ | 0.22 % |
| 66 | IONIS PHARMACEUTICALS INC | 10,319 | 818.2K $ | 0.21 % |
| 67 | Erasca Inc | 42,899 | 785.9K $ | 0.21 % |
| 68 | Cencora Inc | 2,761 | 781.3K $ | 0.20 % |
| 69 | Charles River Laboratories International Inc | 3,410 | 773.4K $ | 0.20 % |
| 70 | Exelixis Inc | 13,864 | 754.3K $ | 0.20 % |
| 71 | Scholar Rock Holding Corp | 13,630 | 749.7K $ | 0.20 % |
| 72 | NATERA INC | 2,738 | 743.2K $ | 0.19 % |
| 73 | Glaukos Corp | 5,290 | 739.3K $ | 0.19 % |
| 74 | ELANCO ANIMAL HEALTH INC | 28,619 | 704.3K $ | 0.18 % |
| 75 | West Pharmaceutical Services Inc | 1,944 | 697.9K $ | 0.18 % |
| 76 | Daiichi Sankyo Co Ltd | 41,900 | 673.8K $ | 0.18 % |
| 77 | Intellia Therapeutics Inc | 39,811 | 673.6K $ | 0.18 % |
| 78 | Agios Pharmaceuticals Inc | 16,266 | 603.6K $ | 0.16 % |
| 79 | VIRIDIAN THERAPEUTICS INC | 31,305 | 575.1K $ | 0.15 % |
| 80 | Eikon Therapeutics Inc | 43,100 | 562.5K $ | 0.15 % |
| 81 | Novocure Ltd | 34,399 | 521.1K $ | 0.14 % |
| 82 | AKTIS ONCOLOGY INC | 16,038 | 516.9K $ | 0.14 % |
| 83 | VAXCYTE INC | 8,729 | 507.4K $ | 0.13 % |
| 84 | ALUMIS INC | 17,411 | 489.9K $ | 0.13 % |
| 85 | Mettler-Toledo International Inc | 365 | 466.3K $ | 0.12 % |
| 86 | PALVELLA THERAPEUTICS INC | 3,008 | 459.7K $ | 0.12 % |
| 87 | Monte Rosa Therapeutics Inc | 18,858 | 456.4K $ | 0.12 % |
| 88 | Enanta Pharmaceuticals Inc | 29,263 | 426.7K $ | 0.11 % |
| 89 | Tango Therapeutics Inc | 12,904 | 403.4K $ | 0.11 % |
| 90 | Bright Minds Biosciences Inc | 5,663 | 397.5K $ | 0.10 % |
| 91 | RadNet Inc | 6,429 | 396.5K $ | 0.10 % |
| 92 | Bridgebio Pharma Inc | 5,247 | 390.8K $ | 0.10 % |
| 93 | Denali Therapeutics Inc | 14,927 | 383.9K $ | 0.10 % |
| 94 | Relay Therapeutics Inc | 20,317 | 380.1K $ | 0.10 % |
| 95 | KYMERA THERAPEUTICS INC | 3,245 | 372.1K $ | 0.10 % |
| 96 | DYNE THERAPEUTICS INC | 16,708 | 371.1K $ | 0.10 % |
| 97 | Immunome Inc | 17,186 | 364.2K $ | 0.10 % |
| 98 | Immunocore Holdings PLC | 11,435 | 363.1K $ | 0.10 % |
| 99 | Beam Therapeutics Inc | 10,063 | 345.4K $ | 0.09 % |
| 100 | AVALO THERAPEUTICS INC | 17,980 | 332.3K $ | 0.09 % |
Sector breakdown
- Health care 82.1 %
- Unattributed 17.9 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 98.0 %
- GBP 0.8 %
- CHF 0.7 %
- EUR 0.3 %
- JPY 0.2 %
- DKK 0.1 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 94.6 %
- Netherlands 1.4 %
- Israel 1.2 %
- United Kingdom 0.8 %
- Switzerland 0.8 %
- Bermuda 0.4 %
- Belgium 0.3 %
- Japan 0.2 %
- Jersey 0.1 %
- Canada 0.1 %
- British Virgin Islands 0.1 %
- Germany 0.1 %
- Other countries 0.1 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 113 | 347.7M $ | 94.57 % |
| 2 | Netherlands | 1 | 5M $ | 1.36 % |
| 3 | Israel | 1 | 4.4M $ | 1.20 % |
| 4 | United Kingdom | 1 | 2.8M $ | 0.77 % |
| 5 | Switzerland | 2 | 2.8M $ | 0.76 % |
| 6 | Bermuda | 1 | 1.3M $ | 0.35 % |
| 7 | Belgium | 1 | 958.6K $ | 0.26 % |
| 8 | Japan | 1 | 673.8K $ | 0.18 % |
| 9 | Jersey | 1 | 521.1K $ | 0.14 % |
| 10 | Canada | 1 | 397.5K $ | 0.11 % |
| 11 | British Virgin Islands | 1 | 309.9K $ | 0.08 % |
| 12 | Germany | 1 | 236.7K $ | 0.06 % |
Cite this page
Titelia. "Holdings of Health Sciences Portfolio". https://titelia.com/en/funds/S000026043